Quilter Plc lowered its stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 9.4% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 8,530 shares of the electronics maker’s stock after selling 880 shares during the period. Quilter Plc’s holdings in Dolby Laboratories were worth $633,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Dolby Laboratories by 7.1% during the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after buying an additional 502,110 shares during the period. AQR Capital Management LLC grew its position in Dolby Laboratories by 63.6% in the 1st quarter. AQR Capital Management LLC now owns 1,143,978 shares of the electronics maker’s stock valued at $90,946,000 after acquiring an additional 444,718 shares in the last quarter. Jones Financial Companies Lllp grew its position in Dolby Laboratories by 241,160.1% in the 1st quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker’s stock valued at $36,975,000 after acquiring an additional 429,265 shares in the last quarter. Nuveen LLC purchased a new stake in Dolby Laboratories during the first quarter worth about $16,890,000. Finally, Martingale Asset Management L P acquired a new stake in shares of Dolby Laboratories during the first quarter worth about $15,366,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Insiders Place Their Bets
In other news, SVP Shriram Revankar sold 7,000 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the company’s stock in a transaction dated Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at approximately $7,901,110.75. This trade represents a 17.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 57,000 shares of company stock valued at $4,037,690. 38.39% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on DLB
Dolby Laboratories Stock Performance
Shares of NYSE DLB opened at $64.98 on Thursday. The stock’s 50-day simple moving average is $68.81 and its 200-day simple moving average is $72.46. The firm has a market capitalization of $6.23 billion, a PE ratio of 23.80 and a beta of 0.97. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same period in the prior year, the firm posted $0.61 earnings per share. The firm’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. On average, sell-side analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be paid a dividend of $0.36 per share. The ex-dividend date is Tuesday, December 2nd. This represents a $1.44 annualized dividend and a yield of 2.2%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio (DPR) is 48.35%.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Further Reading
- Five stocks we like better than Dolby Laboratories
- What Makes a Stock a Good Dividend Stock?
- Applied Materials: Up 40% in 2025 With Room to Run Long-Term
- Insider Buying Explained: What Investors Need to Know
- onsemi Places a $6 Billion Bet on Its Own Stock
- How to Invest in Biotech Stocks
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
